deLaforcade Armelle, Bacek Lenore, Blais Marie-Claude, Goggs Robert, Lynch Alex, Rozanski Elizabeth
Department of Clinical Sciences, Cummings School of Veterinary Medicine at Tufts University, North Grafton, MA.
Department of Clinical Sciences, College of Veterinary Medicine, Auburn University, Auburn, AL.
J Vet Emerg Crit Care (San Antonio). 2019 Jan;29(1):37-48. doi: 10.1111/vec.12797.
Thrombosis is a well-recognized phenomenon in dogs and cats with a significant impact on morbidity and mortality. Despite growing awareness of thrombosis and increased use of antithrombotic therapy, there is little information in the veterinary literature to guide the use of anticoagulant and antiplatelet medications. The goal of Domain 1 was to explore the association between disease and thrombosis in a number of conditions identified as potential risk factors in the current veterinary literature, to provide the basis for prescribing recommendations.
A population exposure comparison outcome format was used to represent patient, exposure, comparison, and outcome. Population Exposure Comparison Outcome questions were distributed to worksheet authors who performed comprehensive searches, summarized the evidence, and created guideline recommendations that were reviewed by domain chairs. Revised guidelines then underwent the Delphi survey process to reach consensus on the final guidelines. Diseases evaluated included immune-mediated hemolytic anemia, protein-losing nephropathy, pancreatitis, glucocorticoid therapy, hyperadrenocorticism, neoplasia, sepsis, cerebrovascular disease, and cardiac disease.
Academic and referral veterinary medical centers.
Of the diseases evaluated, a high risk for thrombosis was defined as dogs with immune-mediated hemolytic anemia or protein-losing nephropathy, cats with cardiomyopathy and associated risk factors, or dogs/cats with >1 disease or risk factor for thrombosis. Low or moderate risk for thrombosis was defined as dogs or cats with a single risk factor or disease, or dogs or cats with known risk factor conditions that are likely to resolve in days to weeks following treatment.
Documented disease associations with thrombosis provide the basis for recommendations on prescribing provided in subsequent domains. Numerous knowledge gaps were identified that represent opportunities for future study.
血栓形成是犬猫中一种广为人知的现象,对发病率和死亡率有重大影响。尽管对血栓形成的认识不断提高,抗血栓治疗的使用也有所增加,但兽医文献中几乎没有信息可指导抗凝和抗血小板药物的使用。第1领域的目标是探讨在当前兽医文献中被确定为潜在危险因素的多种病症中疾病与血栓形成之间的关联,为处方建议提供依据。
采用人群暴露比较结局格式来表示患者、暴露因素、对照因素和结局。人群暴露比较结局问题分发给工作表作者,他们进行全面搜索、总结证据并制定指南建议,这些建议由领域主席进行审查。修订后的指南随后经过德尔菲调查过程,以就最终指南达成共识。评估的疾病包括免疫介导性溶血性贫血、失蛋白性肾病、胰腺炎、糖皮质激素治疗、肾上腺皮质功能亢进、肿瘤、败血症、脑血管疾病和心脏病。
学术和转诊兽医医疗中心。
在评估的疾病中,血栓形成的高风险定义为患有免疫介导性溶血性贫血或失蛋白性肾病的犬、患有心肌病及相关危险因素的猫,或患有>1种疾病或血栓形成危险因素的犬/猫。血栓形成的低或中度风险定义为具有单一危险因素或疾病的犬或猫,或患有已知危险因素且治疗后几天至几周内可能缓解的犬或猫。
已记录的疾病与血栓形成的关联为后续领域提供的处方建议提供了依据。确定了许多知识空白,这代表了未来研究的机会。